Pittsburgh, PA · Health Care · Form D filed Sep 2, 2026
Telemachus Therapeutics, Inc. raised $125K
Telemachus Therapeutics, Inc. is a pharmaceutical company based in Pittsburgh, Pennsylvania. In a Form D filed with the SEC on September 2, 2026, it reported raising $125,000 from 1 investor as part of an offering of up to $1,500,000. The first sale in the offering took place on August 20, 2026.
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
- Still raising. $1.4M of the $1.5M offering was still unsold at filing.
$125K raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 2, 2026 | $125K | $1.5M | 1 |
Lead score
33 out of 100
first raise ever still raising young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $125,000
- Offering size
- $1,500,000
- Investors so far
- 1
- Minimum investment
- $50,000
- First sale
- August 20, 2026
- Securities offered
- Options or warrants, Securities issuable on exercise or conversion, Other
- Exemption claimed
- Rule 506(b)
- Industry
- Pharmaceuticals
- Headquarters
- Pittsburgh, Pennsylvania
- Incorporated
- Delaware, 2026
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $125,000 | $1,500,000 | 1 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 31, 2026 · Health Care funding in Pennsylvania · September 2026 funding report
Similar raises
Admirra, Inc.
Pittsburgh, PA · filed Oct 162nd Form D since 2025Still raising
Pipe Force AI, Inc.
Pittsburgh, PA · filed Oct 155th Form D since 2025
ATJustice, PBC
Pittsburgh, PA · filed Oct 13
Find a qualified lawyer near you. ATJustice
First Form DStill raising
Peca Labs, Inc.
Pittsburgh, PA · filed Oct 9
10th Form D since 2015Still raising
Lungpacer Medical, Inc.
Exton, PA · filed Oct 147th Form D since 2017Still raising
Plowshare Holdings LLC
Lititz, PA · filed Oct 142nd Form D since 2026Still raising
Myris Therapeutics, Inc.
Sharpsburg, PA · filed Oct 142nd Form D since 2022Still raising
EpiVario Inc.
Philadelphia, PA · filed Oct 13
5th Form D since 2018Still raising